Skip to main content
Log in

Pharmacokinetics of 1,4-Butanediol in Rats: Bioactivation to γ-Hydroxybutyric Acid, Interaction with Ethanol, and Oral Bioavailability

  • Research Article
  • Published:
The AAPS Journal Aims and scope Submit manuscript

Abstract

1,4-Butanediol (BD), a substance of abuse, is bioactivated to γ-hydroxybutyrate (GHB), but its fundamental pharmacokinetics (PK) have not been characterized. Because this bioactivation is partly mediated by alcohol dehydrogenase, we hypothesized that there may also be a metabolic interaction between ethanol (ETOH) and BD. We therefore studied, in rats, the plasma PK of GHB, BD and ETOH each at two intravenous (IV) doses, when each substance was given alone, and when GHB or BD was co-administered with ETOH. Results showed that bioconversion of intravenously administered BD to GHB was complete, and that both GHB and BD exhibited nonlinear PK. Various population PK models were analyzed using NONMEM VI, and the best disposition model was found to include two PK compartments each for BD, an (unmeasured) putative semialdehyde intermediate (ALD), GHB and ETOH, the presence of nonlinear (Michaelis–Menten) elimination for each compound, and several mutual inhibition processes. The most prominent mutual metabolic inhibition was found between ETOH and BD, while that between GHB and ETOH was not significant. In vitro studies using liver homogenates confirmed mutual metabolic inhibitions between GHB and BD. Oral absorption of BD was best described by a first-order process with lag-time and pre-systemic metabolism from BD to ALD. Oral absorption of BD (as BD plus ALD) was rapid and complete. The fraction of the absorbed dose entering the central compartment as BD was 30% for the 1.58 mmol/kg dose and 55% for the 6.34 mmol/kg dose. At 6.34 mmol/kg IV, the onset of loss of righting reflex (LRR) for BD was significantly delayed vs. that produced by GHB (72.0 ± 9.1 min vs. 6.7 ± 0.6 min, respectively, p < 0.001), and the total duration of LRR was prolonged for BD vs. GHB (192 ± 28 min vs. 117 ± 2 min, respectively, p < 0.05). Relative to IV dosing, oral BD produced similar but more variable LRR effects. These results may provide a quantitative PK framework for the understanding of the toxicokinetics and toxicodynamics of both BD and GHB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. A. Camacho, S. C. Matthews, B. Murray, and J. E. Dimsdale. Use of GHB compounds among college students. Am. J. Drug Alcohol Abuse 31(4):601–607 (2005).

    Article  PubMed  Google Scholar 

  2. J. Lettieri, and H. L. Fung. Absorption and first-pass metabolism of 14C-gamma-hydroxybutyric acid. Res. Commun. Chem. Pathol. Pharmacol. 13(3):425–437 (1976).

    PubMed  CAS  Google Scholar 

  3. J. Lettieri, and H. L. Fung. Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone. Res. Commun. Chem. Pathol. Pharmacol. 22(1):107–118 (1978).

    PubMed  CAS  Google Scholar 

  4. J. T. Lettieri, and H. L. Fung. Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat. J. Pharmacol. Exp. Ther. 208(1):7–11 (1979).

    PubMed  CAS  Google Scholar 

  5. R. D. Irwin. NTP summary report on the metabolism, disposition, and toxicity of 1,4-butanediol (CAS No. 110-63-4). Toxic. Rep. Ser. 54:1–28, A21–28, B21–25 (1996).

  6. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193(1):265–275 (1951).

    PubMed  CAS  Google Scholar 

  7. K. M. Boje, and H. L. Fung. Characterization of the pharmacokinetic interaction between nifedipine and ethanol in the rat. J. Pharmacol. Exp. Ther. 249(2):567–571 (1989).

    PubMed  CAS  Google Scholar 

  8. S. L. Beal, L. B. Sheiner, A. J. Boechmann (eds.). NONMEM Users Guides. Version 6, Icon Development Solutions, Ellicott City, 1989–2006.

  9. H. L. Fung, E. Haas, J. Raybon, J. Xu, and S. M. Fung. Liquid chromatographic-mass spectrometric determination of endogenous gamma-hydroxybutyrate concentrations in rat brain regions and plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 807(2):287–291 (2004).

    Article  CAS  Google Scholar 

  10. D. K. Van Sassenbroeck, P. De Paepe, F. M. Belpaire, and W. A. Buylaert. Characterization of the pharmacokinetic and pharmacodynamic interaction between gamma-hydroxybutyrate and ethanol in the rat. Toxicol. Sci. 73(2):270–278 (2003).

    Article  PubMed  Google Scholar 

  11. H. Matsumoto, T. Fujimiya, and Y. Fukui. Role of alcohol dehydrogenase in rat ethanol elimination kinetics. Alcohol Alcohol Suppl. 29(1):15–20 (1994).

    PubMed  CAS  Google Scholar 

  12. J. Shimada, T. Miyahara, S. Otsubo, N. Yoshimatsu, T. Oguma, and T. Matsubara. Effects of alcohol-metabolizing enzyme inhibitors and beta-lactam antibiotics on ethanol elimination in rats. Jpn. J. Pharmacol. 45(4):533–544 (1987).

    Article  PubMed  CAS  Google Scholar 

  13. M. S. Mumenthaler, J. L. Taylor, and J. A. Yesavage. Ethanol pharmacokinetics in white women: nonlinear model fitting versus zero-order elimination analyses. Alcohol Clin. Exp. Res. 24(9):1353–1362 (2000).

    Article  PubMed  CAS  Google Scholar 

  14. H. Matsumoto, Y. Minowa, Y. Nishitani, and Y. Fukui. An allometric model for predicting blood ethanol elimination in mammals. Biochem. Pharmacol. 57(2):219–223 (1999).

    Article  PubMed  CAS  Google Scholar 

  15. J. G. Wagner, P. K. Wilkinson, and D. A. Ganes. Parameters Vm' and Km for elimination of alcohol in young male subjects following low doses of alcohol. Alcohol Alcohol 24(6):555–564 (1989).

    PubMed  CAS  Google Scholar 

  16. F. Poldrugo, and O. C. Snead 3rd. 1,4-Butanediol and ethanol compete for degradation in rat brain and liver in vitro. Alcohol 3(6):367–370 (1986).

    Article  PubMed  CAS  Google Scholar 

  17. F. Poldrugo, S. Barker, M. Basa, F. Mallardi, and O. C. Snead. Ethanol potentiates the toxic effects of 1,4-butanediol. Alcohol Clin. Exp. Res. 9(6):493–497 (1985).

    Article  PubMed  CAS  Google Scholar 

  18. F. Poldrugo, and O. C. Snead 3rd. Effect of ethanol and acetaldehyde on gamma-hydroxybutyric acid in rat brain and liver. Subst. Alcohol Actions Misuse 5(5):263–271 (1984).

    PubMed  CAS  Google Scholar 

  19. W. J. Jusko, J. R. Koup, and G. Alvan. Nonlinear assessment of phenytoin bioavailability. J. Pharmacokinet. Biopharm. 4(4):327–336 (1976).

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by NIH grant DA14988.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ho-Leung Fung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fung, HL., Tsou, PS., Bulitta, J.B. et al. Pharmacokinetics of 1,4-Butanediol in Rats: Bioactivation to γ-Hydroxybutyric Acid, Interaction with Ethanol, and Oral Bioavailability. AAPS J 10, 56–69 (2008). https://doi.org/10.1208/s12248-007-9006-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12248-007-9006-3

Key words

Navigation